Top compounds associated with response to ADGRF2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib UHNBreast pan-cancer AAC -0.21 0.5
mRNA Gemcitabine gCSI pan-cancer AAC -0.18 0.002
mRNA PD-0325901 gCSI pan-cancer AAC -0.15 0.004
mRNA Doxorubicin gCSI pan-cancer AAC -0.15 0.005
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.13 0.07
mRNA avicin D CTRPv2 pan-cancer AAC -0.13 0.02
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.13 0.07
mRNA Irinotecan gCSI pan-cancer AAC -0.12 0.03
mRNA paclitaxel gCSI pan-cancer AAC -0.12 0.03
mRNA Docetaxel gCSI pan-cancer AAC -0.12 0.03
Download CSV